History and Future
The Clinical Investigation Center (CIC) is based at the Hawkshead campus and has expanded considerably in recent years.
Cavalier King Charles Spaniel Clinical Study
The Veterinary Clinical Investigation Center has completed a clinical study evaluating the efficacy of a novel treatment for the control of pain associated with syringomyelia in Cavalier King Charles Spaniels.
The study was part of a collaborative effort between a Pharmaceutical Company, and the Schools of Veterinary Medicine at the University of Minnesota, the University of Pennsylvania and the Royal Veterinary College in the United Kingdom. The study actively recruited patients from November 2007 to October 2008 and after screening 119 dogs a total of fifty two patients participated in the trial.
Following statistical analysis the results are promising and there is potential for further development of this new medication to help alleviate the pain associated with syringomyelia.
Many Thanks to those of you who took part - your support is much appreciated.
Investigator Dr Holger A Volk DVM DipECVN PhD MRCVS
Past studies
The Clinical Investigation Center is heavily involved with ongoing research into canine and feline diabetes. Past studies in this area include a Minimed trial to evaluate a Continuous Glucose Monitoring System (CGMS – MiniMed, Northridge, USA) for use in the clinical management of pet dogs with naturally occurring diabetes mellitus
In addition to this, the CIC was instrumental in investigating of the efficacy of Trilostane (Vetoryl®). This is a treatment for hyperadreocorticism which is currently the only licensed product for this disease avaliable in practice.
Future studies
Future studies will include the continuation of previous neurology studies. This year the Clinical Investigations Centre will be working with the neurology team to evaluate a new treatment for canine epilepsy
We will also be continuing our work on Canine Inflammatory bowel disease and atopic dermatitis
For more information explore our Current Trials section.